3 five-star ASX 200 shares I would buy in 2023

These three shares might be the ones to shine brightly for investors in 2023 and beyond.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you looking to make some additions to your portfolio in 2023? If you are, the three ASX 200 shares listed below could be great options.

I believe these shares could generate solid returns for investors in the future thanks to their strong business models and positive long-term outlooks. Here's why they could be five-star stocks.

A girl wearing a homemade rocket launches through the stars.

Image source: Getty Images

Altium Limited (ASX: ALU)

The first five-star ASX 200 share that I would buy next year is Altium. It is the tech company behind the Altium Designer printed circuit board design (PCB) software.

PCBs are the boards you find in most electronic devices. They are integral to their operation and come in all shapes and sizes which means that specialist software is required for their design.

Altium's software is regarded as the best in the industry and is used by high-profile companies and organisations such as BAE Systems, Dell, Microsoft, NASA, and Tesla.

With demand increasing thanks to favourable tailwinds such as the Internet of Things and artificial intelligence booms, management is forecasting strong growth over the coming years. This includes growing its revenue to US$500 million by FY 2026. This will be more than double FY 2022's revenue of US$220.8 million.

CSL Limited (ASX: CSL)

Another five-star ASX 200 share for investors to consider buying in 2023 is CSL. It's one of the world's leading biotherapeutics companies with a portfolio of life-saving, world-class therapies and vaccines. Its products are used around the world to treat immunodeficiencies, bleeding disorders, hereditary angioedema, Alpha 1 antitrypsin deficiency, and neurological disorders.

The company also recently added treatments for iron deficiency, nephrology and cardio-renal to its arsenal through the acquisition of Vifor Pharma for $17 billion. Together with its improving plasma collections and its US$1 billion+ annual spend on R&D, I believe CSL is well placed for growth over the long term.

Xero Limited (ASX: XRO)

A final five-star ASX 200 share that I would buy in 2023 is Xero. It is a cloud accounting platform provider which has been growing at a consistently solid rate for some years. This led to the company reaching 3.5 million subscribers globally during the first half of FY 2023.

Pleasingly, Xero's subs growth looks unlikely to end here. Management estimates that it has a global market opportunity of 45 million subscribers. This provides the company with a significant runway for growth over the next decade and beyond.

Combined with price increases, its burgeoning app store, and the structural shift to online accounting, I believe Xero can continue its strong top-line growth for the foreseeable future.

Motley Fool contributor James Mickleboro has positions in Altium, CSL, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Altium, CSL, Microsoft, and Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Cheerful man in a orange shirt standing in front of an audience holding a tablet and using hand gestures to interact with the audience.
Growth Shares

3 amazing ASX growth shares that continue to stand out

Looking for growth options? Here are three to consider.

Read more »

Person pointing finger on on an increasing graph which represents a rising share price.
Growth Shares

2 ASX shares tipped to grow at least 50% in the next 12 months

These stocks could be some of the best ones to own today.

Read more »

Scared looking people on a rollercoaster ride representing volatility.
Growth Shares

What's driving the wild swings in Telix shares?

The ASX biotech stock offers high-growth potential, but it comes with volatility.

Read more »

An executive in a suit smooths his hair and laughs as he looks at his laptop feeling surprised and delighted.
Growth Shares

3 stellar ASX growth shares to buy now with 30% to 70% upside

Analysts have buy ratings and lofty price targets on these shares.

Read more »

Person using a calculator with four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX shares that I rate as buys today for both growth and dividends!

These businesses have plenty going for them. I’m calling them buys…

Read more »

Two excited woman pointing out a bargain opportunity on a laptop.
Share Market News

NextDC shares rocket 27% higher: Buy, hold or sell?

Can NextDC shares keep climbing higher, or have they now peaked?

Read more »

A woman on a green background points a finger at graphic images of molecules, a rocket, light bulbs, and scientific symbols as she smiles.
Growth Shares

3 exciting ASX shares you won't want to miss out on

These ASX shares are not just growing. They are expanding into much larger opportunities.

Read more »

A woman standing on the street looks through binoculars.
Growth Shares

Here are the latest growth forecasts for the Wesfarmers share price

Bunnings and Kmart could be unstoppable forces in the years ahead.

Read more »